Efficacy of the I-CARE Digital Health Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorDartmouth-Hitchcock Medical Center

About this trial

When presenting to an ED with suicide, self-harm or other mental health crises, youth may also experience "boarding", which is defined by the Joint Commission as "the practice of holding patients in the ED or another temporary location after the decision to admit or transfer has been made." A recent national survey of 88 US acute care hospitals conducted by our research team found that 98.9% of hospitals were boarding youth awaiting psychiatric hospitalization, for an average of 2-3 days. However, as illustrated in a systemic review, little research has focused on developing interventions to support youth during this highly vulnerable time. 3

I-CARE is a modular, blended digital health intervention facilitated by individuals who are not mental health clinical staff to teach youth evidence-based psychosocial skills during the boarding period. This study will evaluate I-CARE's efficacy using a patient-level randomized clinical trial (RCT), randomizing youth to receive standard safety supervision or I-CARE in addition to standard safety supervision. If found to the efficacious, I-CARE could be scaled-up in new settings with limited resources and has the potential to significantly improve the quality of care received by youth experiencing boarding.

Eligibility criteria

Qualifiers

Adolescents of any sex and gender, aged 12-17 years at ED visit or hospital encounter

Presenting with suicide attempt or ideation, or self-harm

Medically stable

English-speaking

Disqualifiers

Cognitive or developmental delays precluding participation (intellectual functioning <12 years of age)

Behavioral limitations that preclude program participation

Active psychosis

Legal parent/caregiver unable to speak English or unavailable to provide consent (e.g. Wards of the State)

Trial design

Treatments tested in this trial

  • Improving Care, Accelerating Recovery & Education (ICARE)

Treatment groups

173 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dartmouth-Hitchcock Medical Center

Lead sponsor

Trustees of Dartmouth College

Sponsor institution

Yale University

Collaborator

Weill Medical College of Cornell University

Collaborator

Dartmouth College

Collaborator